Latest Conference Articles

IPG: Inflammatory Bowel Disease Chaired by Bruce Sands, MD

IPG: Inflammatory Bowel Disease Chaired by Bruce Sands, MD

July 12th 2021, 6:00pm

Institutional Perspectives in Gastroenterology: Inflammatory Bowel Disease Chaired by Bruce Sands, MD

This edition of HCPLive® State of the Science involves 3 experts discussing different trends in IBD treatments and care.

ASPC 2021 Virtual Summit on CVD Prevention Taking Place July 23-25

ASPC 2021 Virtual Summit on CVD Prevention Taking Place July 23-25

July 12th 2021, 10:00am

Conference

The virtual sessions will cover a litany of topics in the greater spectrum of cardiovascular disease prevention and care.

Dennis Bruemmer, MD: Defining a New Era of Diabetes Care

Dennis Bruemmer, MD: Defining a New Era of Diabetes Care

July 1st 2021, 8:00pm

American Diabetes Association

Dennis Bruemmer, MD discusses new agents and perspectives on care in treating patients with type 2 diabetes at high risk of CV, renal complications.

New Research Calls for Greater Focus on Food Security in YYA Patients with Diabetes

New Research Calls for Greater Focus on Food Security in YYA Patients with Diabetes

July 1st 2021, 4:00pm

American Diabetes Association

Investigators say that dietary habits in youth and young adult patients with diabetes can be impacted by income, employment, ethnicity, and a variety of other factors.

Etrolizumab Reduces Genes Associated with Inflammation in Ulcerative Colitis Patients

Etrolizumab Reduces Genes Associated with Inflammation in Ulcerative Colitis Patients

July 1st 2021, 1:00pm

The treatment resulted in a significant reduction in expression of genes representing T & B lymphocytes, plasma cells/plasmablasts, and myeloid cells.

Elaine M. Apperson, MD: Discussing Treatment in Pediatric Patients with Type 1 Diabetes

Elaine M. Apperson, MD: Discussing Treatment in Pediatric Patients with Type 1 Diabetes

July 1st 2021, 10:00am

American Diabetes Association

Elaine M. Apperson discusses treating diabetes in a pediatric population, including diabetes burnout, the effects of food deserts, and the consequences of COVID-19 on treatment.

Canagliflozin Linked to Reduction in Renal, CV Events Across Geographic Regions

Canagliflozin Linked to Reduction in Renal, CV Events Across Geographic Regions

June 30th 2021, 7:00pm

American Diabetes Association

Data show event rates varied two-fold across regions, with risk reduction of T2D and CKD events across geographic regions without heterogeneity.

Elena A Christofides, MD: Obesity Management in Type 2 Diabetes Patients

Elena A Christofides, MD: Obesity Management in Type 2 Diabetes Patients

June 30th 2021, 4:00pm

American Diabetes Association

Part 2 of a Q&A with Elena Christofides, MD highlighting important discussions surrounding ADA 2021, including semaglutide and obesity treatments as they relate to T2D.

New Study Seeks to Increase Vaccination Rate in Patients with Type 2 Diabetes

New Study Seeks to Increase Vaccination Rate in Patients with Type 2 Diabetes

June 30th 2021, 1:00pm

American Diabetes Association

Researchers push for transparency between health care professionals and patients with diabetes about the safety and efficacy of the influenza vaccine

Elena A Christofides, MD: Perspectives on Risk Factors, Care for Type 1 Diabetes Patients

Elena A Christofides, MD: Perspectives on Risk Factors, Care for Type 1 Diabetes Patients

June 29th 2021, 10:00pm

American Diabetes Association

In part 1 of a Q&A, Elena Christofides, MD highlights important discussions surrounding ADA 2021, including cardiometabolic medicine and risk factors for T1D.